EuroNeuroTrophin

21 February 2018

EuroNeuroTrophin
Back to News

AvantiCell Science is delighted to be one of eight beneficiary companies involved in the European Union Horizon 2020 framework programme - EuroNeuroTrophin (www.euroneurotrophin.eu)

 

This is a European training network for the discovery of small molecule neurotrophin mimetics as candidate therapeutic agents for neurodegeneration and neuroinflammation.

 

Read the EuroNeuroTrophin press release here.